Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Anti-diabetic medication Stories

2014-02-13 23:01:43

The Firm is evaluating Byetta lawsuits and other legal claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis, and thyroid cancer due their use of incretin mimetic medications used to treat Type 2 diabetes. New York, New York (PRWEB) February 13, 2014 As Byetta lawsuits (http://www.byettalawsuit.com) and other legal claims involving incretin mimetic drugs continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that U.S. health regulators...

2014-02-11 08:32:23

LA CHAUX-DE-FONDS, Switzerland, February 11, 2014 /PRNewswire/ -- Kareus Therapeutics SA ("Kareus") announced today that US FDA has approved its Investigational New Drug (IND) KU-5039 to initiate Phase I clinical trial. KU 5039 is being developed for the treatment of insulin resistance and diabetes. KU-5039 is an orally active, New Chemical Entity (NCE), discovered and developed by Kareus. KU-5039 is a potent and selective activator of AMP-kinase (AMPK), a key...

2014-02-11 08:30:24

Research advances in novel pathways produce innovative antidiabetic drugs, which will pave the way for successful market penetration LONDON, Feb. 11, 2014 /PRNewswire/ -- Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million people have been diagnosed with diabetes in Europe in 2012, and this number is expected to rise to 64 million by 2030. A recent research by Frost &...

2014-02-08 23:03:08

National network of attorneys is providing consumer updates and no-cost consultations over allegations that the use of the diabetes medication Actos can cause patients to develop bladder cancer. San Diego, CA (PRWEB) February 08, 2014 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople today announced today its latest update for consumers who are following litigation* involving allegations that the use of Actos to treat diabetes can cause...

2014-01-29 23:29:07

Schlichter, Bogard & Denton, LLP is investigating and pursuing claims on behalf of individuals who allege that they have been diagnosed with bladder cancer after taking the diabetes medication Actos® for more than one year. St. Louis, MO (PRWEB) January 29, 2014 The first trial in the Multidistrict Litigation In re: Actos® (Pioglitazone) Products Liability Litigation, MDL 2299, begins on Monday, January 27, 2014 with opening statements expected to occur on February 3, 2014....

2014-01-29 16:29:02

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2qlc2k/lexicons_lx4211) has announced the addition of the "Lexicon's LX4211 - FDA canagliflozin decision is key bellweather" [http://www.researchandmarkets.com/research/2qlc2k/lexicons_lx4211 ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) LX4211 is part of a new class of type 2 diabetes agents that inhibit the SGLT2...

Early Diabetes Detection Basic Blood Test
2014-01-28 08:29:45

redOrbit Staff & Wire Reports - Your Universe Online A basic blood test used by diabetics to gauge their average blood glucose control over a two to three month period could also help diagnose the condition far earlier than previously believed, according to a new study appearing in the European Journal of General Practice. According to researchers from Tel Aviv University's Sackler Faculty of Medicine and Clalit Health Services in Israel, an estimated 25.8 million Americans have...

2014-01-25 23:02:06

The Firm is investigating Byetta lawsuits that allege an association between the use of Byetta and pancreatic cancer, as well as pancreatitis and thyroid cancer. New York, New York (PRWEB) January 25, 2014 Product liability claims alleging, among other things, an association between diabetes drugs like Byetta and pancreatic cancer (http://www.byettalawsuit.com/byetta-pancreatic-cancer/) continue to move forward in state and federal courts around the country, Bernstein Liebhard LLP...

2014-01-23 23:29:58

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Victoza, Janumet, Januvia and Byetta and pancreatic cancer. San Diego, CA (PRWEB) January 23, 2014 http://www.resource4thepeople.com/defectivedrugs/victoza-lawsuit.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations...

2014-01-22 23:30:56

National network of lawyers will resume availability for inquiries from consumers seeking compensation in lawsuits alleging links between diabetes medications Janumet, Januvia, Byetta and Victoza and pancreatic cancer. San Diego, CA (PRWEB) January 22, 2014 http://www.resource4thepeople.com/defectivedrugs/januvia.html Resource4thePeople announced today that its national network of attorneys will continue to offer free consultations in 2014 to consumers inquiring about allegations in...